Patient safety is of utmost importance. Amgen’s Global Patient Safety (GPS) department serves patients by monitoring to ensure a favorable benefit-risk profile of Amgen products (medicines, devices, and combination products) through the practice of Pharmacovigilance. Pharmacovigilance is defined by the World Health Organization as "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine related problem.”

Our approach to pharmacovigilance is rooted in rigorous science and data analytics, robust operating processes, and an in-depth understanding of applicable global regulations. We are dedicated to establishing, monitoring, and communicating product safety information throughout the lifecycle of Amgen products.

Adverse Event and Product Complaint Reporting

Part of Amgen's mission to serve patients includes collecting, reviewing and reporting all Adverse Event or Adverse Experience (AE) information associated with the use of Amgen's investigational or marketed products.